Adjuvant Immunotherapy Ups Survival in dMMR Colon Cancer

By News Health
2 days Ago

(MedPage Today) — CHICAGO — The risk of recurrence or death after surgery for deficient mismatch repair (dMMR) colon cancer decreased by 50% in patients who received immunotherapy in addition to adjuvant chemotherapy, a large randomized trial…

Source link : https://www.medpagetoday.com/meetingcoverage/asco/115839

Author :

Publish date : 2025-06-01 16:50:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Calls for specialist unit in Northern Ireland

Survival in Unresectable Pancreatic Cancer Improved With Tumor Treating Fields

Health Groups Concerned About Cuts in Trump's Proposed 2026 Budget

At-Home Health Tests Are Here, but They Aren't Always the Best Option

Cannabis Use Rises Among U.S. Older Adults

Bivalent CAR-T Cells Via CSF Injection Show Activity in Recurrent Glioblastoma